Characterization of the blastogenic response to LPS of bovine peripheral blood mononuclear cells

PLoS One. 2018 Oct 2;13(10):e0204827. doi: 10.1371/journal.pone.0204827. eCollection 2018.

Abstract

Mitogens are diverse compounds of plant and microbial origin, widely employed to test immunocompetence in animals. The blastogenic response of bovine Peripheral Blood Mononuclear Cells (PBMC) to lypopolysaccharides (LPS) has been investigated in our laboratories for a long time. In particular, a possible correlation between blastogenic response to LPS and disease resistance of periparturient dairy cows had been observed in previous studies. Most important, low responder cows presented a higher frequency of disease cases after calving, compared with high responder animals. Owing to the above, different aspects of the blastogenic response to LPS were investigated on PBMC of healthy Friesian cows, using a 72-hour Bromodeoxyuridin (BrDU) cell proliferation assay. Stimulation with LPS induced little if any replication of bovine PBMC over 72 hours despite consistent BrDU detection in all the PBMC samples under study. Poor replication of LPS-stimulated PBMC was confirmed by cell cycle and cell growth flow cytometry analyses. In particular, LPS stimulation gave rise to very low percentages of S phase cells, sometimes lower than in control, unstimulated cells, as opposed to Concanavalin A-stimulated PBMC. Magnetic separation and analysis of BrDU-treated bovine PBMC after exposure to LPS showed that both B and CD4 T cells are involved in the blastogenic response to LPS, in contrast with current data based on human and murine models. Finally, LPS caused an early, specific up-regulation of TNF-α and TLR4 genes in bovine PBMC, and significant correlations were shown between the expression of inflammatory cytokine and Indoleamine-pyrrole 2,3-dioxygenase (IDO1) genes. On the whole, our data indicate that differences in the blastogenic response to LPS could be partly accounted for by heterogenicity of responding cells (B and T lymphocytes), which might also have an impact on induction and regulation of inflammatory responses and endotoxin tolerance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / metabolism
  • Bromodeoxyuridine / adverse effects*
  • CD4-Positive T-Lymphocytes / cytology*
  • CD4-Positive T-Lymphocytes / metabolism
  • Cattle
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Concanavalin A / pharmacology
  • Female
  • Gene Expression Profiling / veterinary
  • Gene Expression Regulation / drug effects
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / genetics
  • Leukocytes, Mononuclear / cytology*
  • Leukocytes, Mononuclear / drug effects
  • Lipopolysaccharides / adverse effects*
  • Lipopolysaccharides / pharmacology
  • Toll-Like Receptor 4 / genetics
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Lipopolysaccharides
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • Bromodeoxyuridine

Grants and funding

The research was partially supported by MIUR (Ministry for Education, University and Research), Law 232/216 (Department of excellence): Dr. Nicola Lacetera, and partially by internal resources (manpower and consumables) of our organizations. There was no additional external funding received for this study.